Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study

NCT ID: NCT05836480

Last Updated: 2023-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

141 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-05

Study Completion Date

2019-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mitral valve regurgitation is a pathology affecting the left atrioventricular valve, conditioning the loss of the normal unidirectionality of the atrioventricular flow and therefore volumetric and pressure overload of the left heart chambers. In industrialized countries, the most common etiology of mitral regurgitation is degenerative mitral disease.

Mitral valve repair surgery represents the gold standard for the treatment of severe degenerative mitral regurgitation. The expected optimal result would be the absence of residual post-procedural mitral regurgitation, even if it is not uncommon to obtain a valve with residual regurgitation of a mild degree. In some cases, for various reasons (technical difficulties, long aortic clamping time, advanced age, high pre-operative surgical risk), a suboptimal result is accepted, i.e. a post-procedural residual mitral regurgitation of even a moderate degree ( 0, 1+, or 2+/4+).

The aim of the present study is to evaluate the late clinical and echocardiographic implications of suboptimal mitral valve repair with a paired-data cohort study

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitral Regurgitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suboptimal repair

Patients discharged with a residual mitral regurgitation of at least moderate (2+)degree

mitral valve repair

Intervention Type PROCEDURE

conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique

Optimal repair

Patients discharged with a residual mitral regurgitation of mild (1+) or less degree (trace or 0)

mitral valve repair

Intervention Type PROCEDURE

conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mitral valve repair

conservative surgery to treat mitral regurgitation. A mitral valve plasty is performed according to the most appropriate technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Study group:
* presence of severe degenerative mitral regurgitation treated by mitral valve repair between 2006 and 2013;
* presence of moderate residual mitral regurgitation at discharge.
* Control group:
* presence of severe degenerative mitral regurgitation treated by mitral valve repair between 2006 and 2013;
* presence of residual mitral regurgitation of at least mild grade at discharge.

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Michele De Bonis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michele De Bonis

Chief of Cardiac Surgery of Advance and Research Therapies

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Ospedale San Raffaele

Milan, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SUB-MVR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.